Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” fourth quarter 2024 investor letter ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Danaher (NYSE:DHR) and the best and worst ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.

In a report released today, Luke Sergott from Barclays maintained a Hold rating on Danaher (DHR – Research Report), with a price target of $275.00. The company’s shares closed yesterday at ...

Below is Validea's guru fundamental report for DANAHER CORP (DHR). Of the 22 guru strategies we follow, DHR rates highest using our Multi-Factor Investor model based on the published strategy of ...

Danaher Corporation (NYSE: DHR) announced that President and Chief ... today announced availability of new Research Use Only (RUO) blood-based biomarker immunoassays designed to advance ...

Stifel Nicolaus analyst Daniel Arias maintained a Hold rating on Danaher (DHR – Research Report) today and set a price target of $260.00. The company’s shares closed yesterday at $223.73.

Danaher Co. (NYSE:DHR – Free Report) – Equities researchers at Zacks Research dropped their Q2 2025 earnings per share estimates for Danaher in a report released on Wednesday, February 19th.

Panel recommends ICMR to hold inter-ministerial consultation on patent duration: Gireesh Babu, New Delhi Saturday, March 15, 2025, 08:00 Hrs [IST] The Parliamentary Panel on Healt ...

Today we are looking at Danaher (NYSE:DHR) and the best and worst performers in the research tools & consumables industry. The life sciences subsector specializing in research tools and ...